Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
.08 not double, not triple, but 6 time bottom
Going back to green
looks like it was intentional. Now hey can buy their 63 million shares under .10
Wow. look at .08 support
Exactly. Everything submitted to FDA
1 million accumulation. Wow
CLNT $3.24
Keep selling. FDA news any day now per CEO update.
$4s coming. Wow
$90,000+ in bids. Real company. Real trials. FDA update any day now. Says within 60 days. Can be much sooner as well
Dear Shareholders and Friends,
U.S. Stem Cell, Inc. has seen many exciting accomplishments in April. We have curated new partnerships, finalized investments, and received updates on our RMAT designation from the Food and Drug Administration (FDA).
We have recently partnered with Advanced Stem Cell RX in a strategic alliance to commercialize our proprietary applications and protocols. Advanced Stem Cell RX will aid us in implementing U.S. Stem Cell, Inc. programs into qualified practices and clinics in over 20 different states. They will be utilizing our technology to treat patients suffering from degenerative disorders.
On January 27, 2017, U.S. Stem Cell, Inc. applied for the FDA’s new Regenerative Medicine Advanced Therapy (RMAT) designation for the MyoCell™ product as part of the MARVEL trial. After application, the FDA is given 60 days to review it or request additional information. In late March, the FDA requested additional information in order to reinstate our IND (MARVEL trial)—which has been reinstated to active status. Please note that each time more information is requested, the 60-day timeline resets and the FDA is afforded additional regulatory processing time. Currently, U.S. Stem Cell, Inc. is operating within the regulatory timeline and is actively working with the FDA to quickly and effectively fulfill requests for supplementary materials. We will continue to keep our base informed on any FDA communications that affect this timeline.
Read more here: https://goo.gl/K5pvvt
Recently, we announced a new commitment from private equity firm General American Capital Partners (GACP) to invest up to $5 million in U.S. Stem Cell, Inc. in exchange for up to 63,873,275 shares of common stock. GACP has been an avid supporter of U.S. Stem Cell, Inc. and the regenerative medicine industry. We are working together to open Stem Cell Centers of Excellence and to expand our tissue banking facility. With help from companies like GACP, we get closer to our goal of making regenerative medicine more accessible and available to patients all over the world.
Continue reading: https://goo.gl/EFsmrv
Our Chief Science Officer Kristin Comella was featured in Hartman Media’s podcast, “The Longevity and Biohacking – Using Stem Cells to Give Yourself a Better Life.” Kristin was invited to share insights about stem cell treatments and how they can benefit patients suffering from degenerative conditions.
Listen to the podcast here: https://goo.gl/CGtw2U
U.S. Stem Cell, Inc. is committed to the continued development of regenerative medicine technologies and protocols, with our ultimate goal being to make our therapies as accessible as possible to patients around the world. With a strong focus on new, life-changing treatments, our advancements and innovations continue. Stay tuned below to our latest efforts by following us and our various divisions on social media.
Warmest regards,
Mike Tomás
President & CEO
That rip was nuts
USRM $70,000+ on bid. Wow
Guess you were right. Nice gap up p/m
Based on last run and consolidation and continuation of new highs, we are near. Expect new highs by next week
Time for that continued rebound
$1.3 billion that invested today lost money
Have upto 5 days to file
Thank you
USRM shake then new highs as chart shows over and over since .002s
Big buyers $10,000+ now
RMAT coming and going .25+ imo
Trappignmore shorts for squeeze into .10+ and then .25+ imo
Amature selling.
Let's rock this .10+ today and .25+ this week
USRM In addition, GACP has contractually agreed to invest an additional Two and a half Million Dollars ($2,500,000) to open ten (10) stem cell clinics in the United States within 3 years
Big ask order being chewed up. Beauty!
All aboard... time for GREEN
Up trend activated. Let's go 10 days of green again
Over $100,000 traded first 15min.
$1.25+ for USRM is very doable with RMAT FDA APPROVAL and more big investors
Gapping up a bit already
Gm. That's amazing news for USRM. Let's see her break .20s this week
Breaking Story from CNN: Stem cells offer hope for autism
Initial clinical results show safety using a child’s own cord blood stem cells as a potential treatment for Autism. This allows the research to continue into the next phase, which is to study the effectiveness of the treatment.
Stem cells being endorsed all around the world. I believe USRM is next to make a change.
I'm in half of your investment amount and love every minute of it.
Some powerful buys into the close.
Going to be epic next week
All clinics paid for. Wow! Didn't think of that
Strong into close
Over $10,000 BUYS on ask